Literature DB >> 1840863

[Effects of gabexate mesilate (FOY) on the gallbladder, sphincter of Oddi and duodenum of the normal and gastrectomized dogs].

T Yamasato1, M Mori, H Mimura, K Hamazaki, H Kashino, A Gouchi, T Okabayashi, H Tsuge, J Miyake, H Suga.   

Abstract

FOY induced a dose-dependent inhibitory response on the gallbladder, sphincter of Oddi and duodenum of normal and gastrectomized dogs, although it induced an excitatory response in some dogs. The inhibitory response was not reduced or terminated by pretreatment with atropine, guanethidine, hexamethonium or/and proglumide. The FOY-induced inhibitory response reversed to the excitatory response in the sphincter of Oddi and duodenum by pretreatment with tetrodotoxin, but not in the gallbladder. These results suggested that the FOY-induced inhibitory response of the sphincter of Oddi and duodenum was caused by stimulation of nonadrenergic noncholinergic inhibitory neurons, not by FOY-induced cholecystokinin secretion. The excitatory response was induced by direct stimulation of their smooth muscles. The inhibitory response of the gallbladder to FOY was induced by direct stimulation of the smooth muscles.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1840863     DOI: 10.1540/jsmr.27.87

Source DB:  PubMed          Journal:  J Smooth Muscle Res        ISSN: 0916-8737


  2 in total

1.  Effects of gabexate mesilate, a protease inhibitor, on human sphincter of Oddi motility.

Authors:  Vincenzo Di Francesco; Alberto Mariani; Giampaolo Angelini; Enzo Masci; Luca Frulloni; Giorgio Talamini; Sandro Passaretti; Pieralberto Testoni; Giorgio Cavallini
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

2.  Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial.

Authors:  Toshiharu Ueki; Keisuke Otani; Kenichiro Kawamoto; Aiko Shimizu; Naruhito Fujimura; Seigo Sakaguchi; Toshiyuki Matsui
Journal:  J Gastroenterol       Date:  2007-03-12       Impact factor: 7.527

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.